Delivery Order SPE2DR25D2104-SPE2DR26F3QRN
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of BRILINTA 60 MG tablets (60-count packaging). The contract is valued at $1,903.01 with a firm fixed price structure and an ultimate completion date of December 8, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of BRILINTA 90 mg tablets in a quantity of 60 units, with a contract ceiling value of $8,039.34. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement process. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of 60 tablets of BRILINTA 90 mg at a firm fixed price of $10,575.36. This non-set-aside, competitively awarded contract is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $2,638.44 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Brilinta 60 mg tablets (60-count package). This is a firm fixed-price, non-set-aside contract with a completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child action under its...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,682.57 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Brilinta 90 mg tablets (60-count packages). The contract carries a firm fixed price structure with an ultimate completion date of December 8, 2025, and was awarded on a competitive basis with no set-aside designation. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count packages) with a contract value of $16,251.94. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 28, 2025, with an ultimate completion date of December 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.80 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count package) with an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $12,518.91. The order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $10,406.56. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Brilinta 60 mg tablets (60-count packages) with a ceiling value of $3,794.28. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procedures. The contract is scheduled for ultimate completion on December 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QRNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for supply of BRILINTA 60 mg tablets (60-count packages) with a ceiling value of $2,125.24. This non-set-aside, firm fixed-price delivery order is scheduled for ultimate completion by December 5, 2025, with performance originating from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026, which serves as the primary vehicle for pharmaceutical procurement supporting military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical supply procurement through the Defense Logistics Agency and Defense Health Agency. The company's portfolio includes extensive delivery orders for brand-name and generic medications across multiple therapeutic domains. This BRILINTA order represents a routine pharmaceutical delivery under the contractor's established relationship with DLA, which leverages the company's comprehensive supply chain capabilities to support military and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/3/25 |